Skip to main content

Advertisement

Log in

Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

An Erratum to this article was published on 11 April 2017

Abstract

Introduction

Symptom management in patients undergoing palliative chemotherapy is challenging, as patients may suffer from cancer symptoms as well as symptoms related to chemotherapy. Symptom clusters are interrelated symptoms occurring simultaneously that exert a negative impact on survival. Identification of symptom clusters and effective symptom management for patients receiving palliative chemotherapy is crucial.

Objectives

The purpose of this study was to identify symptom clusters among cancer patients undergoing palliative chemotherapy and examine the relationship between symptom clusters and functioning and quality of life (QOL) in these patients.

Methods

A total of 300 patients undergoing palliative chemotherapy participated in the study. Symptom experience during previous palliative chemotherapy was evaluated using a symptom questionnaire including 20 symptoms. The European Organization for Research and Treatment of Cancer Quality of Life-C30 was used to measure patients’ symptoms, functioning and QOL. Factor and hierarchical cluster analyses were performed to identify symptom clusters. Structural equation modeling was used to identify relationships between symptom clusters, functioning and QOL in patients.

Results

Four symptoms clusters including 14 symptoms were identified of the 20 symptoms experienced by patients undergoing palliative chemotherapy. The emotional cluster had negative influence on role and social functioning. The nausea and vomiting/appetite/taste change cluster had a negative impact on role functioning. The fatigue/cognitive and other cluster (dyspnea, pain, constipation, neuropathy, and sleep disturbance) negatively influenced physical functioning. Among the functioning subscales, only role functioning had a direct influence on QOL. Indirect relationships between symptom clusters and QOL were mediated by physical and role functioning. The final model, which consisted of four symptom clusters and three functioning subscales, accounted for 23.3% of the variance in the QOL.

Conclusions

Four symptom clusters occurring during palliative chemotherapy demonstrated negative influences on functioning and QOL. Differential contributions of symptom clusters to functioning were identified that eventually contributed to QOL through role functioning. The identified symptom clusters and their relationships with functioning and QOL may help guide approaches to symptom management. Implementation of interventions targeting symptom clusters would contribute to improving functioning and QOL in patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Roeland EJ, LeBlanc TW (2016) Palliative chemotherapy: oxymoron or misunderstanding? BMC Palliat Care 15:33

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Archer VR, Billingham LJ, Cullen MH (1999) Palliative chemotherapy: no longer a contradiction in terms. Oncologist 4:470–477

    CAS  PubMed  Google Scholar 

  3. Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28:270–282 quiz 283-274

    PubMed  Google Scholar 

  4. Aktas A, Walsh D, Rybicki L (2012) Symptom clusters and prognosis in advanced cancer. Supportive Care in Cancer 20(11):2837–2843

  5. Dong ST, Butow PN, Costa DS, Lovell MR, Agar M (2014) Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manag 48:411–450

    Article  Google Scholar 

  6. Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle C (2011) Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 29:1151–1158

    Article  PubMed  Google Scholar 

  7. Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, Paul SM, West C, Lee K, Swift PS, Wara W, Miaskowski C (2009) Differences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapy. Cancer Nurs 32:429–436

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, Teckle P, Tong A, Tebbutt NC, Clarke SJ, van der Hoek K, King MT, Fayers PM (2016) Symptom clusters in advanced cancer patients: an empirical comparison of statistical methods and the impact on quality of life. J Pain Symptom Manag 51:88–98

    Article  Google Scholar 

  9. Van Lancker A, Beeckman D, Verhaeghe S, Van Den Noortgate N, Van Hecke A (2016) Symptom clustering in hospitalised older palliative cancer patients: a cross-sectional study. Int J Nurs Stud 61:72–81

    Article  PubMed  Google Scholar 

  10. Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14:831–836

    Article  PubMed  Google Scholar 

  11. Comrey AL, Lee HB (1992) A first course in factor analysis. Laurence Erlbaum Associates, Hillsdale, NJ

    Google Scholar 

  12. Raykov T, Marcoulides GA (2006) A first course in structural equation modeling. Laurence Erlbaum Associates, Mahwah, NJ

    Google Scholar 

  13. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 16:791–801

    Article  PubMed  Google Scholar 

  14. Akin S, Durna Z (2013) A comparative descriptive study examining the perceptions of cancer patients, family caregivers, and nurses on patient symptom severity in Turkey. Eur J Oncol Nurs 17:30–37

    Article  PubMed  Google Scholar 

  15. Molassiotis A, Brearley S, Saunders M, Craven O, Wardley A, Farrell C, Swindell R, Todd C, Luker K (2009) Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. J Clin Oncol 27:6191–6198

    Article  PubMed  Google Scholar 

  16. Cirillo M, Venturini M, Ciccarelli L, Coati F, Bortolami O, Verlato G (2009) Clinician versus nurse symptom reporting using the National Cancer Institute-common terminology criteria for adverse events during chemotherapy: results of a comparison based on patient’s self-reported questionnaire. Ann Oncol 20:1929–1935

    Article  CAS  PubMed  Google Scholar 

  17. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195

    Article  CAS  PubMed  Google Scholar 

  18. Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB (2005) Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13:219–227

    Article  PubMed  Google Scholar 

  19. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89:1634–1646

    Article  CAS  PubMed  Google Scholar 

  20. Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O’Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 106

  21. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326–1336

    Article  CAS  PubMed  Google Scholar 

  22. Rha SY, Song SK, Lee CE, Park Y, Lee J (2016) Gaps exist between patients’ experience and clinicians’ awareness of symptoms after chemotherapy: CINV and accompanying symptoms. Support Care Cancer

  23. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13:863–868

    Article  CAS  PubMed  Google Scholar 

  24. Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J 6:1–55

    Article  Google Scholar 

  25. Thomas BC, Waller A, Malhi RL, Fung T, Carlson LE, Groff SL, Bultz BD (2014) A longitudinal analysis of symptom clusters in cancer patients and their sociodemographic predictors. J Pain Symptom Manag 47:566–578

    Article  Google Scholar 

  26. Yennurajalingam S, Kwon JH, Urbauer DL, Hui D, Reyes-Gibby CC, Bruera E (2013) Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care 11:473–480

    Article  PubMed  Google Scholar 

  27. Aktas A, Walsh D, Hu B (2014) Cancer symptom clusters: an exploratory analysis of eight statistical techniques. J Pain Symptom Manag 48:1254–1266

    Article  Google Scholar 

  28. Ye ZJ, Liang MZ, Qiu HZ, Liu ML, GY H, Zhu YF, Zeng Z, Zhao JJ, Quan XM (2016) Effect of a multidiscipline mentor-based program, Be resilient to breast cancer (BRBC), on female breast cancer survivors in mainland China-a randomized, controlled, theoretically-derived intervention trial. Breast Cancer Res Treat 158:509–522

    Article  PubMed  Google Scholar 

  29. Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21:735–748

    Article  PubMed  Google Scholar 

  30. Huang J, Gu L, Zhang L, Lu X, Zhuang W, Yang Y (2016) Symptom clusters in ovarian cancer patients with chemotherapy after surgery: a longitudinal survey. Cancer Nurs 39:106–116

    Article  PubMed  Google Scholar 

  31. Olver IN, Eliott JA, Koczwara B (2014) A qualitative study investigating chemotherapy-induced nausea as a symptom cluster. Support Care Cancer 22:2749–2756

    Article  PubMed  Google Scholar 

  32. Molassiotis A, Farrell C, Bourne K, Brearley SG, Pilling M (2012) An exploratory study to clarify the cluster of symptoms predictive of chemotherapy-related nausea using random forest modeling. J Pain Symptom Manag 44:692–703

    Article  Google Scholar 

  33. Kim HJ, Barsevick AM, Tulman L, McDermott PA (2008) Treatment-related symptom clusters in breast cancer: a secondary analysis. J Pain Symptom Manag 36:468–479

    Article  Google Scholar 

  34. Stapleton SJ, Holden J, Epstein J, Wilkie DJ (2016) Symptom clusters in patients with cancer in the hospice/palliative care setting. Support Care Cancer 24:3863–3871

    Article  PubMed  Google Scholar 

  35. Skerman HM, Yates PM, Battistutta D (2012) Cancer-related symptom clusters for symptom management in outpatients after commencing adjuvant chemotherapy, at 6 months, and 12 months. Support Care Cancer 20:95–105

    Article  PubMed  Google Scholar 

  36. Van Lancker A, Velghe A, Van Hecke A, Verbrugghe M, Van Den Noortgate N, Grypdonck M, Verhaeghe S, Bekkering G, Beeckman D (2014) Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manag 47:90–104

    Article  Google Scholar 

  37. Jordhoy MS, Fayers P, Loge JH, Saltnes T, Ahlner-Elmqvist M, Kaasa S (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85:1478–1485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The current study was supported in part by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (2012R1A1A1010107 and 2015R1A1A1A05001342), in part by the Chungnam National University Research fund (2015-1728-01), and in part by the grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1520190).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiyeon Lee.

Ethics declarations

Conflict of interest

The authors have no conflict of interest. They have full control of all primary data and agree to allow the journal to review their data if requested.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00520-017-3705-9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rha, S.Y., Lee, J. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life. Support Care Cancer 25, 1519–1527 (2017). https://doi.org/10.1007/s00520-016-3545-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3545-z

Keywords

Navigation